Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

CSL Limited (ASX:CSL)

Pharmaceuticals, Biotechnology & Life Sciences

CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.

CSL Limited (ASX:CSL) share price

CSL Limited (ASX:CSL) share price news

australian shares report graphic
ASX Growth Shares
Drew Meredith, CFP

S&P/ASX 200 price bounces, Rio Tinto circles Turquoise Hill

The S&P/ASX 200 (INDEXASX: XJO) managed a small gain on Wednesday, adding 0.1 per cent, as strength in the energy and materials sectors offset losses in property. Rio Tinto Limited’s (ASX:RIO) interest in Turquoise Hill has got investors thinking.

Skip to content